Perrigo Company plc (PRGO) 

Perrigo Company plc provides over-the-counter (OTC) health and wellness solutions that enhance individual well-being by empowering consumers to prevent or treat conditions that can be self-managed. The company operates through two segments, Consumer Self-Care Americas and Consumer Self-Care International. The Consumer Self-Care Americas segment focuses primarily on the development, manufacture, marketing, and sale of store brand, self-care products in categories, including upper respiratory, pain and sleep-aids, digestive health, nutrition, vitamins, minerals and supplements, healthy lifestyle, skincare and personal hygiene, and oral self-care in the United States, Mexico, Canada, and South America. The segment offers its products under the Prevacid 24HR, Good Sense, Zephrex D, ScarAway, Plackers, Rembrandt, Steripod, Firefly, REACH, Dr. Fresh, and Burt's Bees brand names. The Consumer Self-Care International segment develops, manufactures, markets, and distributes consumer self-care brands through a network of pharmacies, wholesalers, drug and grocery store retailers, and para-pharmacies in approximately 23 countries, primarily in Europe. The company also offers contract manufacturing services. Perrigo Company plc was founded in 1887 and is headquartered in Dublin, Ireland.

Show less

Over the last 12 months, insiders at Perrigo Company plc have bought $1.25M and sold $0 worth of Perrigo Company plc stock.

On average, over the past 5 years, insiders at Perrigo Company plc have bought $1.52M and sold $2.31M worth of stock each year.

Highest buying activity among insiders over the last 12 months: Lockwood-Taylor Patrick (CEO) — $571,036. Willis Robert (EVP & CHRO) — $337,083. Bezerra Eduardo Guarita (EVP & Chief Financial Officer) — $291,763.

The last purchase of 1,000 shares for transaction amount of $27,900 was made by Andersen Svend (EVP & President CHCI) on 2024‑05‑28.